CD4 and leukemia: While most of these studies are in solid tumors31–34, we and others have demonstrated the potency of IL-12 in promoting immunologic elimination of leukemia cells, dependent upon both CD4+ and CD8+ T-cells, and to a lesser extent NK cells15, 35.